Digital health company Better Therapeutics has submitted its lead prescription digital therapeutic (DTx) BT-001 to the FDA, seeking approval for use by adults with type 2 diabetes (T2D).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback